Skip to content
Search

Latest Stories

Pharmacists must change focus from accuracy to safety: CEO of Community Pharmacy Scotland

Professor Harry McQuillan has said community pharmacists in the UK must change their focus from an ‘accuracy of supply’ to a ‘safety of supply’ model when it comes to dealing with patients.

“The main take away message from tonight’s lecture is for pharmacy professionals to really challenge themselves about whether they are focused on accuracy of supply or safety of supply," he said at this year’s UCL School of Pharmacy Lecture in London on Thursday, 15 June.


“For our community pharmacists it must be about safety, including prescribing, and ensuring patients and citizens get the maximum benefit from prescribed medicines.

“To deliver this, we need to invest in our teams -- harness technology and always be willing to take the next step in a more clinical future.”

The Chief Executive Office of Community Pharmacy Scotland, however, noted that at a time when the UK was grappling with an unprecedented national debt crisis exacerbated by severe cost of living and spiraling inflation, community pharmacy will need to make a “compelling case" of where the priority should be in the sector.

Expanding on the financial woes of the country, he compared the current national debt of the UK, which stood at a staggering 270 percent of GDP in September 2022, with the previous record-breaking national debt of 250 per cent at the end of WWII.

“There will be no immediate change in this position,” he warned.

He said the changing political dynamics in all four nations – while England, Scotland and Wales have had their own fair share of fairly new ministerial appointments, Northern Ireland is facing a power vacuum – will mean that it will be more difficult for the sector in each nation to engage with their respective government machinery.

Earlier, in his opening address, Mark Lyonette, CEO of the National Pharmacy Association, set the tone of the event by saying that the sector's moment had finally arrived in the last few years.

"Despite all the obvious and real funding challenges across the UK for community pharmacy, it really does feel like community pharmacy’s moment has well and truly arrived in the last few years" he said with a health warning: "some of you might think it a bit controversial", arguing that "over those last few years we have seen, in different ways and in different parts of the UK, that the perceptions of what the sector can offer, can contribute have been changing mostly for the better."

Expanding on how these 'changing perceptions' had started making a mark in the corridors of power, Lyonette added: "I went back to HM Treasury last week and for the first time in five years as the Chief Executive of the NPA I was delighted to hear that the key question from the Treasury officials was not so much (about) ‘how much does it cost’ (but) it was more of ‘how far can community pharmacy go’."

This was a theme reechoed by McQuillan later in the evening building when he argued that pharmacy was "potentially on the cusp of a transformation".

He praised Wales’ chief pharmaceutical officer and highlighted Andrew Evans' Six C’s principles – something McQuillan felt the sector across the board should embrace and emulate. "Wales’ Six C’s really appeal to me: three C’s for the pharmacists and their teams – capacity, capability and continuity – and in terms of what you deliver from the pharmacy perspective –community, connectivity and collaboration.”

He said he looked forward to tech-enabled community pharmacies keeping people well at home, using prescribed medicine and personalised care. Pharmacist prescribing, he said, would be a key factor ensuring that community pharmacy will remain a critical partner in the delivery of healthcare.

Also speaking at the event held at the Royal Society, Catherine Duggan, CEO International Pharmaceutical Federation, said: “FIP’s vision is for a world where everyone benefits from access to safe, effective, quality and affordable medicines and health technologies, as well as from pharmaceutical care services provided by pharmacists, in collaboration with other healthcare professionals.

"Throughout the pandemic, as the lights went out across all our communities in a global lockdown, community pharmacies, pharmacists and their teams remained open providing access to medicines supplies, advice and expertise in all our communities.

"From the learnings of that time and the visions of our community pharmacy section, FIP is ensuring that community pharmacy continues to meet the needs of patients and the public by providing needs based pharmaceutical care in all communities, nations, regions and the globe.’’

'Pharmacy in England can be Scotland on Steroids'

For his part, Nick Kaye, Chair of the National Pharmacy Association, Kaye said: “It’s time for community pharmacists to step forward with greater confidence into all areas of clinical practice involving medicines use. The extent to which we are successful in delivering NHS prescribing services will be deciding factor in the future of our sector across the UK.

"I am delighted to be associated with this prestigious event, which gives pharmacists permission to remove ourselves momentarily from the day job and contemplate our soul as a profession”.

“Harry’s lecture reminded us that Scotland in so many ways a beacon of excellent pharmaceutical care, even though the challenges there are very real, notably around workforce. My message is that it’s not inevitable that England’s pharmacies should lag behind our counterparts in Scotland and Wales. There’s nothing intrinsic about England’s pharmacists from a skills point of view that means we are incapable of delivering a wider range of clinical services at scale.

"In fact, England’s community pharmacy network could one day be ‘Scotland on Steroids’ – an inspiration and model for others to follow, in the UK and across the world.”

Another discussant, James Davies, Director for England Royal Pharmaceutical Society, said that "the profession is moving away from a focus on the supply of medications towards providing care delivered through services.

"There is an opportunity for a strong future for community pharmacy, through application of pharmacists’ core skills of risk management, improving safety, driving local health promotion and increasingly through independent prescribing," he said.

"To make this happen we will need to step out of existing pharmacy structures and work across the pharmacy professions. Something that has arguably been achieved faster in Scotland and Wales than in England. Today’s lecture provided a platform through which those future opportunities could be discussed and shared”.

Nigel Clarke, former chair of the General Pharmaceutical Council chaired the event, which brought together some 200 pharmacists, students, academics and healthcare stakeholders, to share ideas and good practice.

The 2023 Pharmacy Lecture themed 'Community Pharmacy in the 21st Century NHS' was jointly organised by University College London School of Pharmacy, the Royal Pharmaceutical Society and National Pharmacy Association.

More For You

RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less